AAPL281.85-1.93 (-0.68%) ▼|ABBV255.27+1.92 (+0.76%) ▲|ABT92.83-1.29 (-1.37%) ▼|ACN125.04-3.94 (-3.05%) ▼|ADBE205.97+3.24 (+1.60%) ▲|AMAT697.48+70.64 (+11.27%) ▲|AMD536.72+15.14 (+2.90%) ▲|AMGN359.93+1.60 (+0.45%) ▲|AMT167.94-7.66 (-4.36%) ▼|AMZN240.09+7.40 (+3.18%) ▲|AVGO373.33+8.31 (+2.28%) ▲|AXP341.46+1.10 (+0.32%) ▲|BA215.26-1.99 (-0.92%) ▼|BAC58.04+0.16 (+0.28%) ▲|BKNG183.39+1.93 (+1.06%) ▲|BLK952.72-11.99 (-1.24%) ▼|BMY58.45+0.93 (+1.62%) ▲|BNY144.11+0.55 (+0.38%) ▲|BRK-B495.95-2.71 (-0.54%) ▼|C142.79+1.03 (+0.73%) ▲|CAT1,033.24+35.77 (+3.59%) ▲|CL91.98-0.09 (-0.10%) ▼|CMCSA24.44+1.27 (+5.46%) ▲|COF202.35-1.65 (-0.81%) ▼|COP104.43-1.53 (-1.44%) ▼|COST944.98-7.56 (-0.79%) ▼|CRM158.45+0.08 (+0.05%) ▲|CSCO117.47+3.70 (+3.25%) ▲|CVS103.36-0.98 (-0.94%) ▼|CVX168.84-2.22 (-1.30%) ▼|DE624.07+10.83 (+1.77%) ▲|DHR193.19-3.00 (-1.53%) ▼|DIS98.65-0.14 (-0.14%) ▼|DUK128.03-0.37 (-0.29%) ▼|EMR142.90-0.59 (-0.41%) ▼|FDX324.51+5.98 (+1.88%) ▲|GD348.45+1.74 (+0.50%) ▲|GE373.26+4.26 (+1.15%) ▲|GEV1,099.27+54.10 (+5.18%) ▲|GILD126.10-1.78 (-1.39%) ▼|GM77.52-0.59 (-0.75%) ▼|GOOG350.91+16.22 (+4.84%) ▲|GOOGL353.32+15.93 (+4.72%) ▲|GS1,023.93+4.32 (+0.42%) ▲|HD349.92+1.06 (+0.30%) ▲|HON227.58-15.84 (-6.51%) ▼|IBM277.65+6.02 (+2.22%) ▲|INTC130.38+2.06 (+1.61%) ▲|INTU267.20-0.52 (-0.19%) ▼|ISRG405.76+1.49 (+0.37%) ▲|JNJ257.94+3.28 (+1.29%) ▲|JPM330.84+1.79 (+0.54%) ▲|KO82.58-0.05 (-0.06%) ▼|LIN510.87-8.75 (-1.68%) ▼|LLY1,228.14+20.02 (+1.66%) ▲|LMT503.10-4.30 (-0.85%) ▼|LOW220.15-2.34 (-1.05%) ▼|LRCX409.83+30.74 (+8.11%) ▲|MA510.87+11.85 (+2.37%) ▲|MCD267.18-2.58 (-0.96%) ▼|MDLZ60.11-0.69 (-1.13%) ▼|MDT80.74-0.25 (-0.30%) ▼|META564.45+14.20 (+2.58%) ▲|MMM162.43-1.59 (-0.97%) ▼|MO73.85+0.06 (+0.08%) ▲|MRK129.36+0.70 (+0.54%) ▲|MS212.57+0.54 (+0.25%) ▲|MSFT368.04-4.93 (-1.32%) ▼|MU1,128.19-4.14 (-0.37%) ▼|NEE88.53-0.03 (-0.03%) ▼|NFLX73.88+0.07 (+0.09%) ▲|NKE41.32+0.57 (+1.40%) ▲|NOW99.83+1.49 (+1.52%) ▲|NVDA194.62+2.09 (+1.09%) ▲|ORCL148.25-0.28 (-0.19%) ▼|PEP138.10-3.29 (-2.33%) ▼|PFE24.41+0.12 (+0.49%) ▲|PG147.91-1.11 (-0.74%) ▼|PLTR116.21+3.28 (+2.90%) ▲|PM182.48+1.71 (+0.95%) ▲|QCOM187.52-1.88 (-0.99%) ▼|RTX187.74-0.25 (-0.13%) ▼|SBUX104.11-0.49 (-0.47%) ▼|SCHW90.52-0.16 (-0.17%) ▼|SO96.72-0.44 (-0.45%) ▼|SPG227.69+0.80 (+0.35%) ▲|T21.79-0.93 (-4.09%) ▼|TMO505.11-7.92 (-1.54%) ▼|TMUS173.83-8.86 (-4.85%) ▼|TSLA411.51+31.80 (+8.37%) ▲|TXN284.54-0.89 (-0.31%) ▼|UBER75.20-1.00 (-1.31%) ▼|UNH418.44-9.45 (-2.21%) ▼|UNP272.41+4.06 (+1.51%) ▲|UPS107.98-0.16 (-0.15%) ▼|USB61.40+0.49 (+0.80%) ▲|V342.23+6.00 (+1.78%) ▲|VZ44.09-2.45 (-5.26%) ▼|WFC83.84-0.03 (-0.03%) ▼|WMT114.83-0.86 (-0.74%) ▼|XOM136.09-0.46 (-0.33%) ▼|AAPL281.85-1.93 (-0.68%) ▼|ABBV255.27+1.92 (+0.76%) ▲|ABT92.83-1.29 (-1.37%) ▼|ACN125.04-3.94 (-3.05%) ▼|ADBE205.97+3.24 (+1.60%) ▲|AMAT697.48+70.64 (+11.27%) ▲|AMD536.72+15.14 (+2.90%) ▲|AMGN359.93+1.60 (+0.45%) ▲|AMT167.94-7.66 (-4.36%) ▼|AMZN240.09+7.40 (+3.18%) ▲|AVGO373.33+8.31 (+2.28%) ▲|AXP341.46+1.10 (+0.32%) ▲|BA215.26-1.99 (-0.92%) ▼|BAC58.04+0.16 (+0.28%) ▲|BKNG183.39+1.93 (+1.06%) ▲|BLK952.72-11.99 (-1.24%) ▼|BMY58.45+0.93 (+1.62%) ▲|BNY144.11+0.55 (+0.38%) ▲|BRK-B495.95-2.71 (-0.54%) ▼|C142.79+1.03 (+0.73%) ▲|CAT1,033.24+35.77 (+3.59%) ▲|CL91.98-0.09 (-0.10%) ▼|CMCSA24.44+1.27 (+5.46%) ▲|COF202.35-1.65 (-0.81%) ▼|COP104.43-1.53 (-1.44%) ▼|COST944.98-7.56 (-0.79%) ▼|CRM158.45+0.08 (+0.05%) ▲|CSCO117.47+3.70 (+3.25%) ▲|CVS103.36-0.98 (-0.94%) ▼|CVX168.84-2.22 (-1.30%) ▼|DE624.07+10.83 (+1.77%) ▲|DHR193.19-3.00 (-1.53%) ▼|DIS98.65-0.14 (-0.14%) ▼|DUK128.03-0.37 (-0.29%) ▼|EMR142.90-0.59 (-0.41%) ▼|FDX324.51+5.98 (+1.88%) ▲|GD348.45+1.74 (+0.50%) ▲|GE373.26+4.26 (+1.15%) ▲|GEV1,099.27+54.10 (+5.18%) ▲|GILD126.10-1.78 (-1.39%) ▼|GM77.52-0.59 (-0.75%) ▼|GOOG350.91+16.22 (+4.84%) ▲|GOOGL353.32+15.93 (+4.72%) ▲|GS1,023.93+4.32 (+0.42%) ▲|HD349.92+1.06 (+0.30%) ▲|HON227.58-15.84 (-6.51%) ▼|IBM277.65+6.02 (+2.22%) ▲|INTC130.38+2.06 (+1.61%) ▲|INTU267.20-0.52 (-0.19%) ▼|ISRG405.76+1.49 (+0.37%) ▲|JNJ257.94+3.28 (+1.29%) ▲|JPM330.84+1.79 (+0.54%) ▲|KO82.58-0.05 (-0.06%) ▼|LIN510.87-8.75 (-1.68%) ▼|LLY1,228.14+20.02 (+1.66%) ▲|LMT503.10-4.30 (-0.85%) ▼|LOW220.15-2.34 (-1.05%) ▼|LRCX409.83+30.74 (+8.11%) ▲|MA510.87+11.85 (+2.37%) ▲|MCD267.18-2.58 (-0.96%) ▼|MDLZ60.11-0.69 (-1.13%) ▼|MDT80.74-0.25 (-0.30%) ▼|META564.45+14.20 (+2.58%) ▲|MMM162.43-1.59 (-0.97%) ▼|MO73.85+0.06 (+0.08%) ▲|MRK129.36+0.70 (+0.54%) ▲|MS212.57+0.54 (+0.25%) ▲|MSFT368.04-4.93 (-1.32%) ▼|MU1,128.19-4.14 (-0.37%) ▼|NEE88.53-0.03 (-0.03%) ▼|NFLX73.88+0.07 (+0.09%) ▲|NKE41.32+0.57 (+1.40%) ▲|NOW99.83+1.49 (+1.52%) ▲|NVDA194.62+2.09 (+1.09%) ▲|ORCL148.25-0.28 (-0.19%) ▼|PEP138.10-3.29 (-2.33%) ▼|PFE24.41+0.12 (+0.49%) ▲|PG147.91-1.11 (-0.74%) ▼|PLTR116.21+3.28 (+2.90%) ▲|PM182.48+1.71 (+0.95%) ▲|QCOM187.52-1.88 (-0.99%) ▼|RTX187.74-0.25 (-0.13%) ▼|SBUX104.11-0.49 (-0.47%) ▼|SCHW90.52-0.16 (-0.17%) ▼|SO96.72-0.44 (-0.45%) ▼|SPG227.69+0.80 (+0.35%) ▲|T21.79-0.93 (-4.09%) ▼|TMO505.11-7.92 (-1.54%) ▼|TMUS173.83-8.86 (-4.85%) ▼|TSLA411.51+31.80 (+8.37%) ▲|TXN284.54-0.89 (-0.31%) ▼|UBER75.20-1.00 (-1.31%) ▼|UNH418.44-9.45 (-2.21%) ▼|UNP272.41+4.06 (+1.51%) ▲|UPS107.98-0.16 (-0.15%) ▼|USB61.40+0.49 (+0.80%) ▲|V342.23+6.00 (+1.78%) ▲|VZ44.09-2.45 (-5.26%) ▼|WFC83.84-0.03 (-0.03%) ▼|WMT114.83-0.86 (-0.74%) ▼|XOM136.09-0.46 (-0.33%) ▼|
30.9 C
New York
Monday, June 29, 2026

Tag: option

BioAegis Therapeutics Announces US Navy Contract to Support Phase 2 Study of Recombinant Human Gelsolin, for Inflammasome-Driven Decompression Sickness (DCS)

Phase 2 proof-of-concept study for rhu-pGSN, a promising intervention across a spectrum of inflammatory diseases, to be studied as an intervention for the negative outcomes of decompression in SCUBA Divers
Phase 2 proof-of-concept study for rhu-pGSN, a promising intervention across a spectrum of inflammatory diseases, to be studied as an intervention for the negative outcomes of decompression in SCUBA Divers

BrightSpring Announces Secondary Offering of Common Stock

LOUISVILLE, Ky., June 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ: BTSG) (“BrightSpring” or the “Company”), a leading provider of home and community-based health services for complex populations, today announced that certain of its stockholders (the “Selling Stockholders”), including affiliates of Kohlberg Kravis Roberts & Co. L.P. (the “KKR Selling Stockholder”) and certain members of management, intend to offer for sale in an underwritten secondary offering an aggregate 14,000,000 shares of common stock of BrightSpring pursuant to a shelf registration statement filed by BrightSpring with the U.S. Securities and Exchange Commission (the “SEC”). The KKR Selling Stockholder expects to grant the underwriters a 30-day option to purchase up to an additional 2,100,000 shares of BrightSpring’s common stock. No shares are being sold by BrightSpring in the offering. The Selling Stockholders will receive all of the proceeds from this offering.

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

MINNEAPOLIS, June 10, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a commercial-stage medical device company dedicated to transforming care for fluid overload patients, today announced the closing of a public offering of 2,580,667 shares of its common stock (“Common Stock”), pre-funded warrants to purchase 14,085,998 shares of Common Stock, in each case with accompanying Series A Warrants to purchase up to 49,999,995 shares of Common Stock and Series B Warrants to purchase up to 16,666,665 shares of Common Stock with gross proceeds of approximately $5.0 million, which includes the full exercise of the underwriter’s over-allotment option to purchase additional shares and warrants.

Orchid Island Capital Announces June 2025 Monthly Dividend and May 31, 2025 RMBS Portfolio Characteristics

Vero Beach, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Orchid Island Capital, Inc. (the “Company”) (NYSE: ORC) announced today that the Board of Directors of the Company declared a monthly cash dividend for the month of June 2025. The dividend of $0.12 per share will be paid July 30, 2025 to holders of record of the Company’s common stock on June 30, 2025, with an ex-dividend date of June 30, 2025. The Company plans on announcing its next common stock dividend on July 9, 2025.

AMSC Announces Proposed Public Offering of Common Stock

AYER, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- American Superconductor Corporation (Nasdaq: AMSC), a leading system provider of megawatt-scale power resiliency solutions that orchestrate the rhythm and harmony of power on the grid™ and protect and expand the capability and resiliency of our Navy’s fleet, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. AMSC also expects to grant the underwriters a 30-day option to purchase additional shares of common stock offered in the public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. AMSC intends to use the net proceeds from the proposed offering for working capital and general corporate purposes, including potential strategic acquisitions.

Karat Packaging Inc. Announces Proposed Secondary Offering of Common Stock

CHINO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Karat Packaging Inc. (Nasdaq: KRT) (“Karat” or the “Company”), a specialty distributor and manufacturer of disposable foodservice products and related items, today announced the commencement of a proposed underwritten public offering of 1,500,000 shares of Karat’s common stock by certain members of the Company’s management team (the “Selling Stockholders”). The Selling Stockholders will also grant the underwriter a 30-day option to purchase up to an additional 225,000 shares of Karat’s common stock offered in the offering from the Selling Stockholders.

Alpha 1 SPV Limited Announces Option Agreement to Sell its Interest in Elemental Altus Royalties Corp.

ABU DHABI, UAE, June 10, 2025 /CNW/ - AlphaStream Limited today announces that it and its affiliate, Alpha 1 SPV Limited (together with AlphaStream Limited,...

Tether Investments Announces Acquisition of Securities of Elemental Altus Royalties Corp.

/NOT FOR DISTRIBUTION TO US NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ Acquisition Underscores Tether Investment's Long-Term Vision Around Gold-Backed Financial Infrastructure SAN SALVADOR,...

Carnival Corporation’s ‘Less Left Over’ Strategy Beats Targets, Delivers Significant Food Waste Reduction Progress

World's largest cruise company reduced food waste per person by 44% over the last five years,surpassing its 2025 40% target vs 2019 one year...

First Commercial Implants of WiSE System for CRT patients

SUNNYVALE, Calif., June 10, 2025 /PRNewswire/ -- In a major milestone for heart failure treatment, the first commercial patients in the U.S. have been...

K9 Resorts Unleashes First-Ever Summer Camp to Promote Physical, Mental + Social Stimulation for Dogs

The Luxury Pet Care Brand Launches Eight-Week Themed Summer Camps to Enrich Dogs' LivesPet Parents Can Add Structured Fun to Their Dog's Routine While...

Cineverse Announces Commercial Availability of cineSearch for Business – a Revolutionary, AI-Powered Tool that Solves Search & Discovery for Digital Platforms and Streaming Services

Company's Proprietary, Customizable Product is "AI for your UI" that Improves the Viewer Search Experience, User Retention and Time Spent in a Cost-Effective Way cineSearch...

Cisco Transforms Security for the Agentic AI Era, Further Fusing Security into the Network

Latest innovations safeguard AI workloads and agents, give security teams cutting-edge tools to protect against increasingly sophisticated threats News Summary: Cisco is building secure infrastructure for...

Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination Granted U.S. FDA Priority Review for First-Line Maintenance Treatment of Extensive-Stage Small Cell Lung Cancer

Target Action (PDUFA) Date set for October 7, 2025 Application based on data from IMforte, the first Phase 3 trial demonstrating statistically significant and clinically...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsOption